title: [The outlook for the development of live vaccines for the prevention of melioidosis].
abstract: The effectiveness of immunization with Burkholderia pseudomallei attenuated strains (Pur and Ts), heterologous vaccines and the recombinant culture of Francisella tularensis RM2 carrying a plasmid with fragments of B. pseudomallei chromosome was studied in four species of experimental animals, essentially differing in their sensitivity to melioidosis. The most immunogenic B. pseudomallei mutants, introduced subcutaneously, created a statistically significant level of protection in animals, moderately sensitive to melioidosis, but proved to be ineffective in highly sensitive animal models when tested under the same conditions. In aerogenic infection the effectiveness of the experimental vaccines under study in all species of the animals was on the same level. The study showed good prospects of using tularemia vaccine for inducing heterologous immunity to melioidosis, as well as the possibility of its use as the basis of a bivalent gene-engineering vaccine.
authors.affiliation: Research Institute for Plague Control, Volgograd, Russia.
authors.forename: V I
authors.initials: VI
authors.lastname: Iliukhin
authors.forename: N N
authors.initials: NN
authors.lastname: Kislichkin
authors.forename: L K
authors.initials: LK
authors.lastname: Merinova
authors.forename: L A
authors.initials: LA
authors.lastname: Riapis
authors.forename: I I
authors.initials: II
authors.lastname: Denisov
authors.forename: S M
authors.initials: SM
authors.lastname: Farber
authors.forename: O I
authors.initials: OI
authors.lastname: Kislichkina
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology*; D016957:Burkholderia pseudomallei / Q000276:immunology* / Q000472:pathogenicity; D004353:Drug Evaluation, Preclinical; D005604:Francisella tularensis / Q000276:immunology; D006168:Guinea Pigs; D008554:Melioidosis / Q000517:prevention & control*; D014613:Vaccines, Attenuated / Q000276:immunology; D017778:Vaccines, Combined / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014774:Virulence / Q000276:immunology
chemical_list: D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined; D014614:Vaccines, Synthetic
vernacular_title: Perspektivy razrabotki zhivykh vaktsin dlia profilaktiki melioidoza.